SWShiqi Wang

Shiqi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shiqi Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher J. Lingle

    Department of Anesthesiology, Washington University School of Medicine, St Louis, USA

    2 shared publications
  • Hailan Hu

    School of Brain Science and Brain Medicine, New Cornerstone Science Laboratory, Zhejiang University School of Medicine, Hangzhou, China

    2 shared publications
  • Haohong Li

    Nanhu Brain–Computer Interface Institute, MOE Frontier Science Center for Brain Science and Brain–Machine Integration, State Key Laboratory of Brain–Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou, China

    2 shared publications
  • Huan Ma

    Department of Neurology of Second Affiliated Hospital and Liangzhu Laboratory, School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, China

    2 shared publications
  • Junying Wang

    Nanhu Brain–Computer Interface Institute, MOE Frontier Science Center for Brain Science and Brain–Machine Integration, State Key Laboratory of Brain–Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou, China

    2 shared publications
  • Min Chen

    Nanhu Brain–Computer Interface Institute, MOE Frontier Science Center for Brain Science and Brain–Machine Integration, State Key Laboratory of Brain–Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Author Correction: Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb

    by Shuangshuang Ma, Min Chen, Yihao Jiang, Xinkuan Xiang, Shiqi Wang, Zuohang Wu, Shuo Li, Yihui Cui, Junying Wang, Yanqing Zhu, et al.


  • Top Cited Papers
    Open Access

    Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb

    by Shuangshuang Ma, Min Chen, Yihao Jiang, Xinkuan Xiang, Shiqi Wang, Zuohang Wu, Shuo Li, Yihui Cui, Junying Wang, Yanqing Zhu, et al.

    Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist1, has revolutionized the treatment of depression because of its potent, rapid and sustained antidepressant effects2–4. Although the elimination half-life of ketamine is only 13 min in mice5, its antidepressant activities can last for at least 24 h6–9. This large discrepancy poses an interesting basic biological question and has strong clinical implications. Here we demonstrate that after a single systemic injection, ketamine continues to suppress burst firing and block NMDARs in the lateral habenula (LHb) for up to 24 h. This long inhibition of NMDARs is not due to endocytosis but depends on the use-dependent trapping of ketamine in NMDARs. The rate of untrapping is regulated by neural activity. Harnessing the dynamic equilibrium of ketamine–NMDAR interactions by activating the LHb and opening local NMDARs at different plasma ketamine concentrations, we were able to either shorten or prolong the antidepressant effects of ketamine in vivo. These results provide new insights into the causal mechanisms of the sustained antidepressant effects of ketamine. The ability to modulate the duration of ketamine action based on the biophysical properties of ketamine–NMDAR interactions opens up new opportunities for the therapeutic use of ketamine.